# 2025-14335: FDA Eyes Cholesterol Treats to Supercharge Honeybee Diets

2025-14335, APIX Biosciences US LLC; Filing of Food Additive Petition (Animal Use), is a Federal Register proposed rule from Health and Human Services Department, Food and Drug Administration published 2025-07-29 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-14335
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-14335
- Title: APIX Biosciences US LLC; Filing of Food Additive Petition (Animal Use)
- Type: Proposed Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 35645
- Published: 2025-07-29
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Eyes Cholesterol Treats to Supercharge Honeybee Diets

## Summary

APIX Biosciences wants the FDA to approve using cholesterol safely in honeybee food. This change could help beekeepers feed their bees better, keeping them healthy. If approved, it might start soon and won’t cost extra for most folks, but it’s a big win for buzzing buddies everywhere!

## Abstract

The Food and Drug Administration (FDA or we) is announcing that we have filed a food additive petition, submitted by APIX Biosciences US LLC, proposing that we amend our food additive regulations to provide for the safe use of cholesterol as a source of sterol in food for honeybees at a level between 0.009 and 0.5% by weight of the food.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-14335 on federalregister.gov](https://www.federalregister.gov/documents/2025/07/29/2025-14335/apix-biosciences-us-llc-filing-of-food-additive-petition-animal-use)
- [2025-14335 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-07-29/pdf/2025-14335.pdf)

## Related
- [Previous: 2025-14333, Intent To Establish Negotiated Rulemaking Committees; Correction](https://policyrisk.com/federal-register/2025-14333)
- [Next: 2025-14339, Spoonbill Foundation; Filing of Food Additive Petition](https://policyrisk.com/federal-register/2025-14339)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-14335 (as of 2026-06-08).
